RO5428029

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RO5428029, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C [Phase 1]